PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Insertable balloons – Market size and forecast 2017-2022 • Swallowable balloons – Market size and forecast 2017-2022 • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Vendors focus on technological advances • Increasing preference toward weight loss procedures PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Allurion Technologies • Apollo Endosurgery • Helioscopie • Obalon Therapeutics • ReShape Lifesciences • Spatz FGIA PART 15: APPENDIX • List of abbreviations     Exhibit 01: Global bariatric surgery devices market Exhibit 02: Global bariatric surgery devices market segmentation Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Global intragastric balloons market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global intragastric balloons market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global intragastric balloons market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Global intragastric balloons market – Market share by product 2017-2022 (%) Exhibit 19: Global intragastric balloons market – Comparison by product Exhibit 20: Major insertable intragastric balloons Exhibit 21: Global insertable balloons market – Market size and forecast 2017-2022 ($ mn) Exhibit 22: Global insertable balloons market – Year-over-year growth 2018-2022 (%) Exhibit 23: Major swallowable intragastric balloons Exhibit 24: Global swallowable balloons market – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Global swallowable balloons market – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Global intragastric balloons market – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Intragastric balloons market in Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Intragastric balloons market in Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top 3 countries in Americas Exhibit 33: Intragastric balloons market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: Intragastric balloons market in EMEA – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in EMEA Exhibit 36: Intragastric balloons market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: Intragastric balloons market in APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top 3 countries in APAC Exhibit 39: Market opportunity Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Allurion Technologies – Overview Exhibit 46: Allurion Technologies – Business segments Exhibit 47: Allurion Technologies – Organizational developments Exhibit 48: Allurion Technologies – Geographic focus Exhibit 49: Allurion Technologies – Key offerings Exhibit 50: Allurion Technologies – Key customers Exhibit 51: Apollo Endosurgery – Overview Exhibit 52: Apollo Endosurgery – Product segments Exhibit 53: Apollo Endosurgery – Organizational developments Exhibit 54: Apollo Endosurgery – Geographic focus Exhibit 55: Apollo Endosurgery – Segment focus Exhibit 56: Apollo Endosurgery – Key offerings Exhibit 57: Apollo Endosurgery – Key customers Exhibit 58: Helioscopie – Overview Exhibit 59: Helioscopie – Business segments Exhibit 60: Helioscopie – Organizational developments Exhibit 61: Helioscopie – Key offerings Exhibit 62: Helioscopie – Key customers Exhibit 63: Obalon Therapeutics – Overview Exhibit 64: Obalon Therapeutics – Business segments Exhibit 65: Obalon Therapeutics – Organizational developments Exhibit 66: Obalon Therapeutics – Geographic focus Exhibit 67: Obalon Therapeutics – Key offerings Exhibit 68: Obalon Therapeutics – Key customers Exhibit 69: ReShape Lifesciences – Overview Exhibit 70: ReShape Lifesciences – Business segments Exhibit 71: ReShape Lifesciences – Organizational developments Exhibit 72: ReShape Lifesciences – Key offerings Exhibit 73: ReShape Lifesciences – Key customers Exhibit 74: Spatz FGIA – Overview Exhibit 75: Spatz FGIA – Business segments Exhibit 76: Spatz FGIA – Organizational developments Exhibit 77: Spatz FGIA – Key offerings Exhibit 78: Spatz FGIA – Key customers

Allurion Technologies Apollo Endosurgery Helioscopie Obalon Therapeutics ReShape Lifesciences Spatz FGIA